Tolebrutinib for non-relapsing secondary progressive multiple sclerosis: a critical therapeutic gap

Authors
Category Primary study
JournalMed.
Year 2025
This article has no abstract
Epistemonikos ID: 0d3dac1d6c08bcc02ee88d8904df168ffc119c2b
First added on: Aug 02, 2025